Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting

This publication has 56 references indexed in Scilit:

• Integrins in glioblastoma: Still an attractive target?
  Pharmacological Research, 2016
• The role of integrins in primary and secondary brain tumors
  2016
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
  The Lancet Oncology, 2014
• Glioblastoma cancer stem cells – From concept to clinical application
  Cancer Letters, 2013
• Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line
  The Journal of Steroid Biochemistry and Molecular Biology, 2010
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
  The Lancet Oncology, 2009
• β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
  Cancer Research, 2008
• JNK phosphorylates paxillin and regulates cell migration
  Nature, 2003
• Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors.
  2003
• Elevated JNK activation contributes to the pathogenesis of human brain tumors
  Oncogene, 2002